Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

FDA critics slam plan for safety reform

Calls grow for independent supervision of US drug regulation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Authors

Additional information

Alliance for Human Research Protection, New York

Related links

Related links

Related links in Nature Research

Antidepressants: In Focus

Antibiotics: In Focus

Related external links

FDA

Drug Safety Initiative

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marris, E. FDA critics slam plan for safety reform. Nature (2005). https://doi.org/10.1038/news050214-11

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/news050214-11

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing